Faye Elliott

6.6k citations

56 papers · 2.4k indexed · h-index 22

Impact in

Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cutaneous Melanoma Detection and Management
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer
- Vitamin D Research Studies

Papers in

Oncology 33
- Colorectal Cancer Treatments and Studies 20
- Cutaneous Melanoma Detection and Management 8
Dermatology 7

Co-authors: Jennifer H. Barrett Susan D. Richman Michel Seymour Philip Quirke D. Timothy Bishop Angela Meade Catherine Daly Julia Newton‐Bishop
Journals: Journal of Clinical Oncology (9 papers)Annals of Oncology (7 papers)British Journal of Cancer (3 papers)Journal of Investigative Dermatology (2 papers)Carcinogenesis (2 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Faye Elliott

54 papers receiving 2.3k citations

Peers

Countries citing papers authored by Faye Elliott

Since Specialization

Citations

This map shows the geographic impact of Faye Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye Elliott more than expected).

Fields of papers citing papers by Faye Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye Elliott. The network helps show where Faye Elliott may publish in the future.

Co-authors

The 25 scholars most cited alongside Faye Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Faye Elliott Line = papers co-authored together Faye Elliott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CT staging performance in an international trial of neoadjuvant chemotherapy for locally advanced colon cancer British Journal of Radiology ·d. Smith Bailey, Faye Elliott, Kelly Handley, Laura Magill, Philip Quirke, Michel Seymour, Nicholas P. West, Dion Morton, Jenny F. Seligmann, Damian Tolan	2025	0
2	552P Baseline imaging biomarkers to predict outcomes in locally advanced colon cancer (LACC): Data from the FOxTROT international randomised-controlled trial Annals of Oncology ·d. Smith Bailey, Faye Elliott, Philip Quirke, 陽之平賀, Michel Seymour, Maria Ordóñez Abrigo, Kelly Handley, 이병걸, Damian Tolan, Jenny F. Seligmann	2024	1
3	Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank Rheumatology Advances in Practice ·Gao Chun-ying, John Taylor, Faye Elliott, E. O'Sullivan, Ann W Morgan, Jennifer H. Barrett, Sarah Mackie	2023	3
4	552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel Annals of Oncology ·Jenny F. Seligmann, Dion Morton, Michel Seymour, Faye Elliott, Kelly Handley, Bengt Glimelius, Christopher J.M. Williams, Gemma Hemmings, L Costamagna, Richard Gray, Philip Quirke, Laura Magill, Andrew D. Beggs, Nicholas P. West	2023	3
5	Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone British Journal of Cancer ·Sanne ten Hoorn, Dirkje W. Sommeijer, Faye Elliott, David J. Fisher, Tim R. de Back, Anne Trinh, Lianne Koens, Tim Maughan, Jenny F. Seligmann, Michel Seymour, Philip Quirke, Richard Adams, Susan D. Richman, Cornelis J.A. Punt, Louis Vermeulen	2021	11
6	Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel Annals of Oncology ·Jenny F. Seligmann, Faye Elliott, Susan D. Richman, Gemma Hemmings, Sarah Brown, Bart Jacobs, Christopher J.M. Williams, Sabine Tejpar, Jennifer H. Barrett, Philip Quirke, Michel Seymour	2020	12
7	Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures Journal of Investigative Dermatology ·Claire Hardie, Faye Elliott, May Chan, Zoe Rogers, D. Timothy Bishop, Julia Newton‐Bishop	2019	21
8	Epidermal growth factor receptor (EGFR) copy number (CN) as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC) Annals of Oncology ·Jenny F. Seligmann, Henry M. Wood, Susan D. Richman, Faye Elliott, Morag Taylor, Emma Tinkler‐Hundal, Jennifer H. Barrett, Michel Seymour, Philip Quirke	2017	2
9	Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials Annals of Oncology ·Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Susan D. Richman, Faye Elliott, Sarah Brown, Richard Adams, Tim Maughan, Philip Quirke, Jeremy P. Cheadle, Michel Seymour, Gary Middleton	2016	124
10	Point of care testing for improving risk- benefit ratio of aspirin and warfarin Molecular Cytogenetics ·Harsh Sheth, Bruno Sousa Costa, Faye Elliott, Michael S. Jackson, Mauro Santibáñez Koref, John R. Tyson, Ann K. Daly, Kazuyoshi TANIKAWA, Jayesh Sheth, Frenny Sheth, Keyur Parikh, D. Timothy Bishop, John Burn	2014	1
11	A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis Cancer Prevention Research ·John Burn, D. Timothy Bishop, Pamela Chapman, Faye Elliott, Lucio Bertario, Malcolm G. Dunlop, Diana Eccles, Anthony E. Ellis, D. Gareth Evans, Riccardo Fodde, Eamonn R. Maher, Gabriela Möslein, Hans F. A. Vasen, Pilar Rodríguez Maestu, Robin Phillips, Steffen Bülow, John C. Mathers	2011	151
12	The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes Carcinogenesis ·Mark Teo, Debora Landi, Claire Taylor, Faye Elliott, Laurence Vaslin, David G. Cox, Janet Hall, Stefano Landi, D. Timothy Bishop, Anne E. Kiltie	2011	91
13	The determinants of serum vitamin D levels in participants in a melanoma case–control study living in a temperate climate Cancer Causes & Control ·John R. Davies, Yu‐Mei Chang, Helen Snowden, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes, Kairen Kukalizch, Juliette A. Randerson‐Moor, Faye Elliott, Julian H. Barth, Peter A. Kanetsky, Mark Harland, D. Timothy Bishop, Jennifer H. Barrett, Julia Newton‐Bishop	2011	30
14	Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients BMC Medical Genetics ·Boling Qiao, Gina B. Scott, Faye Elliott, Laurence Vaslin, Johanne Bentley, Janet Hall, D. Timothy Bishop, Margaret A. Knowles, Anne E. Kiltie	2011	3
15	Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom Cancer Epidemiology Biomarkers & Prevention ·Julia Newton‐Bishop, Yu‐Mei Chang, Mark M. Iles, John Taylor, Egbert Bakker, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes, 明石, Faye Elliott, Peter A. Kanetsky, Mark Harland, Jennifer H. Barrett, D. Timothy Bishop	2010	70
16	MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer Cancer Research ·Ananya Choudhury, JenniferL . Thompson, Mark Teo, Ruixin Jin, Selina Bhattarai, C.F. Johnston, Faye Elliott, Jiaqiang Ni, Claire Taylor, Michael Churchman, Johanne Bentley, Margaret A. Knowles, Patricia Harnden, Robert G. Bristow, D. Timothy Bishop, Anne E. Kiltie	2010	149
17	Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma Genes Chromosomes and Cancer ·Caroline Conway, Samantha Beswick, Faye Elliott, Yu‐Mei Chang, Juliette A. Randerson‐Moor, Mark Harland, Paul Affleck, Jerry Marsden, Donita Sanders, Xicheng Feng, Margaret A. Knowles, D. Timothy Bishop, Julia Newton‐Bishop	2010	37
18	Serum 25-Hydroxyvitamin D ₃ Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma Journal of Clinical Oncology ·Julia Newton‐Bishop, Samantha Beswick, Juliette A. Randerson‐Moor, Yu‐Mei Chang, Paul Affleck, Faye Elliott, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes, Kairen Kukalizch, Linda Whitaker, Sharon Jackson, Charles Olufemi Ogundimu, Sarah van de Berg, Chandra Bertram, Jerry Marsden, David E. Elder, Jennifer H. Barrett, D. Timothy Bishop	2009	214
19	Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival Clinical Cancer Research ·Caroline Conway, Angana Mitra, Rosalyn Jewell, Juliette A. Randerson‐Moor, Samira Lobo, Jérémie Nsengimana, Josh W. Leamons, Donita Sanders, Martin Cook, Barry Powell, Xicheng Feng, Faye Elliott, Floor de Kort, Margaret A. Knowles, D. Timothy Bishop, Julia Newton‐Bishop	2009	70
20	Analysis of variants in DNA damage signalling genes in bladder cancer BMC Medical Genetics ·Ananya Choudhury, Faye Elliott, Mark M. Iles, Michael Churchman, Robert G. Bristow, D. Timothy Bishop, Anne E. Kiltie	2008	36

About Faye Elliott

Faye Elliott is a scholar working on Oncology, Dermatology, Pathology and Forensic Medicine, Immunology and Allergy and Cancer Research, having authored 56 papers that have together received 2.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), Cutaneous Melanoma Detection and Management (8 papers), Gastric Cancer Management and Outcomes (8 papers), Genetic factors in colorectal cancer (7 papers), Colorectal and Anal Carcinomas (6 papers), Vitamin D Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Oncology (1.4k citations), Pathology and Forensic Medicine (739 citations), Dermatology (248 citations), Cancer Research (386 citations) and Hepatology (181 citations). Faye Elliott has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Jennifer H. Barrett, Susan D. Richman, Michel Seymour, Philip Quirke, D. Timothy Bishop, Angela Meade, Catherine Daly, Julia Newton‐Bishop, Philip Chambers and Graham R. Taylor. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Journal of Investigative Dermatology and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact